Aeterna Zentaris Inc. | CIK:0001113423 | 3

  • Filed: 3/28/2018
  • Entity registrant name: Aeterna Zentaris Inc. (CIK: 0001113423)
  • Generator: Workiva (WebFilings)
  • SEC filing page: http://www.sec.gov/Archives/edgar/data/1113423/000162828018003635/0001628280-18-003635-index.htm
  • XBRL Instance: http://www.sec.gov/Archives/edgar/data/1113423/000162828018003635/aezs-20171231.xml
  • XBRL Cloud Viewer: Click to open XBRL Cloud Viewer
  • EDGAR Dashboard: https://edgardashboard.xbrlcloud.com/edgar-dashboard/?cik=0001113423
  • Open this page in separate window: Click

    • ifrs-full:DisclosureOfOtherProvisionsExplanatory

     
     
    December 31,
     
     
    2017
     
    2016
     
     
    $
     
    $
    Onerous contract provisions (detailed below)
     
    310

     
    404

    Non-current portion of provision for restructuring costs (note 13)
     
    718

     
    —

    Other
     
    —

     
    97

     
     
    1,028

     
    501

    Onerous contract provisions
     
     
    Cetrotide® onerous contracts*
     
    Onerous lease**
     
    Total
     
     
    $
     
    $
     
    $
    At January 1, 2016
     
    803

     
    234

     
    1,037

    Change in the provision
     
    (24
    )
     
    —

     
    (24
    )
    Utilization of provision
     
    (196
    )
     
    (113
    )
     
    (309
    )
    Unwinding of discount and effect of changes in the discount and foreign exchange rates
     
    (9
    )
     
    4

     
    (5
    )
    At December 31, 2016
     
    574

     
    125

     
    699

    Less: current portion (note 12)
     
    (181
    )
     
    (114
    )
     
    (295
    )
     
     
    393

     
    11

     
    404

     
     
     
     
     
     
     
    At December 31, 2016
     
    574

     
    125

     
    699

    Change in the provision
     
    (20
    )
     
    —

     
    (20
    )
    Utilization of provision
     
    (145
    )
     
    (119
    )
     
    (264
    )
    Unwinding of discount and effect of changes in the discount and foreign exchange rates
     
    64

     
    3

     
    67

    At December 31, 2017
     
    473

     
    9

     
    482

    Less: current portion (note 12)
     
    (163
    )
     
    (9
    )
     
    (172
    )
     
     
    310

     
    —

     
    310

    _________________________
    *
    Recorded following the transfer of the Cetrotide® Business (discontinued operations).
    **
    Represents the present value of the future lease payments that the Company is obligated to make pursuant to a non-cancellable operating lease in the United States, net of estimated future sublease income. The estimate may vary as a result of changes in the utilization of the leased premises and of the sublease arrangement. The lease expired in January 2018.